Amphastar P - Asset Resilience Ratio

Latest as of December 2025: 6.91%

Amphastar P (AMPH) has an Asset Resilience Ratio of 6.91% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Amphastar P total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$112.64 Million

Cash + Short-term Investments

Total Assets

$1.63 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Amphastar P's Asset Resilience Ratio has changed over time. See AMPH book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Amphastar P's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Amphastar P market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$112.64 Million	6.91%
Total Liquid Assets	$112.64 Million	6.91%

Asset Resilience Insights

Limited Liquidity: Amphastar P maintains only 6.91% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Amphastar P Industry Peers by Asset Resilience Ratio

Compare Amphastar P's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Amphastar P (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Amphastar P.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.91%	$112.64 Million	$1.63 Billion	+2.47pp
2024-12-31	4.44%	$70.04 Million	$1.58 Billion	-3.00pp
2023-12-31	7.44%	$112.51 Million	$1.51 Billion	+4.79pp
2022-12-31	2.65%	$19.66 Million	$741.99 Million	+1.11pp
2021-12-31	1.54%	$10.32 Million	$671.53 Million	-0.52pp
2020-12-31	2.06%	$12.98 Million	$631.24 Million	-0.32pp
2019-12-31	2.38%	$13.96 Million	$586.97 Million	+1.83pp
2018-12-31	0.55%	$2.83 Million	$513.56 Million	-0.03pp
2017-12-31	0.58%	$2.63 Million	$454.67 Million	+0.46pp
2016-12-31	0.12%	$527.00K	$427.74 Million	-0.21pp
2015-12-31	0.33%	$1.28 Million	$390.14 Million	-0.05pp
2014-12-31	0.38%	$1.50 Million	$389.37 Million	-0.01pp
2013-12-31	0.39%	$1.32 Million	$338.75 Million	-0.20pp
2012-12-31	0.59%	$1.89 Million	$317.48 Million	--

pp = percentage points

About Amphastar P

NASDAQ:AMPH USA Drug Manufacturers - Specialty & Generic

Market Cap

$992.70 Million

Market Cap Rank

#9285 Global

#2462 in USA

Share Price

$21.88

Change (1 day)

-0.36%

52-Week Range

$18.18 - $30.81

All Time High

$65.00